ModuleDraftMedications
Study module: antithrombotics in stroke (antiplatelet vs anticoagulant) — decision concepts
Study-focused framework for antithrombotic decisions after ischemic stroke/TIA: antiplatelet vs anticoagulation based on mechanism, dual antiplatelet timing concept, and safety considerations (no dosing).
ClinicianClinicianAdvanced30 minClinical (pro)
Educational only
Educational only — antithrombotic decisions require guideline criteria and patient-specific assessment.
Get help now
Severe bleeding, head injury on antithrombotics, or suspected acute stroke is an emergency: activate local emergency response immediately. Document antithrombotic agent and last known dose time if available.
Key takeaways
- Differentiate antiplatelet vs anticoagulant mechanisms
- Map stroke mechanism categories to antithrombotic strategy themes
- Describe dual antiplatelet therapy (DAPT) short-course concept in select minor stroke/TIA
- Identify bleeding-risk counseling and monitoring themes
Mechanisms
- Platelet inhibition
- Coagulation pathway inhibition
Etiology → therapy themes
- Non-cardioembolic → antiplatelet-centered strategies
- Cardioembolic (e.g., AFib) → anticoagulation consideration
DAPT concept
- Short course in selected patients
- Timing matters
- Not for all patients
Safety themes
- Bleeding risk
- Drug interactions
- Peri-procedural planning
Practice check
What you’ll practice
These questions are untimed. After you answer all of them, you’ll see your score and a clear next lesson or reference step.
0 of 3 answered